Clinical aspects of diabetic ketoacidosis
1989; Wiley; Volume: 5; Issue: 8 Linguagem: Inglês
10.1002/dmr.5610050803
ISSN1099-0895
AutoresMarthina Streda Walker, Sally M. Marshall, K. G. M. M. Alberti,
Tópico(s)Metabolism and Genetic Disorders
ResumoDiabetes/Metabolism ReviewsVolume 5, Issue 8 p. 651-663 Article Clinical aspects of diabetic ketoacidosis M. Walker, M. Walker Department of Medicine, The Medical School, Framlington Place, Newcastle Upon Tyne NE2 4HH, EnglandSearch for more papers by this authorS. M. Marshall, S. M. Marshall Department of Medicine, The Medical School, Framlington Place, Newcastle Upon Tyne NE2 4HH, EnglandSearch for more papers by this authorK. G. M. M. Alberti, K. G. M. M. Alberti Department of Medicine, The Medical School, Framlington Place, Newcastle Upon Tyne NE2 4HH, EnglandSearch for more papers by this author M. Walker, M. Walker Department of Medicine, The Medical School, Framlington Place, Newcastle Upon Tyne NE2 4HH, EnglandSearch for more papers by this authorS. M. Marshall, S. M. Marshall Department of Medicine, The Medical School, Framlington Place, Newcastle Upon Tyne NE2 4HH, EnglandSearch for more papers by this authorK. G. M. M. Alberti, K. G. M. M. Alberti Department of Medicine, The Medical School, Framlington Place, Newcastle Upon Tyne NE2 4HH, EnglandSearch for more papers by this author First published: December 1989 https://doi.org/10.1002/dmr.5610050803Citations: 21AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Foster DW: Banting Lecture: From glycogen to ketones—and back. Diabetes 33: 1188– 1199, 1984. 2 Marshall SM, and Alberti KGMM: Diabetic ketoacidosis. In The Diabetic Annual/3, KGMM Alberti, and LP Krall, Eds. Elsevier Science Publishers, BV, pp 498– 526, 1987. 3 Alberti KGMM: Diabetic emergencies. Br Med Bull 45: 242– 263, 1989. 4 Alberti KGMM: Diabetic emergencies. Diabetes Mellitus, 9th ed. JA Galloway, JH Potvin, and CR Shuman, Eds. Eli Lilly, Indianapolis, IN, 1987, pp 253– 275. 5 Keller U: Diabetic ketoacidosis: Current views on pathogenesis and treatment. Diabetologia 29: 71– 77, 1986. 6 Faich GA, Fishbein HA, and Ellis SE: The epidemiology of diabetic acidosis: A population-based study. Am J Epidemiol 117: 551– 558, 1983. 7 Scott RS, Brown LJ, and Clifford P: Use of health services by diabetic persons. II Hospital admissions. Diabetes Care 8: 43– 47, 1985. 8 Ellemann K, Soerensen JN, Pedersen L, Edsberg B, and Andersen OO: Epidemiology and treatment of diabetic ketoacidosis in a community population. Diabetes Care 7: 528– 532, 1984. 9 Fishbein HA: Diabetic ketoacidosis, hyperosmolar nonketotic coma, lactic acidosis and hypoglycemia. In Diabetes in America (National Diabetes Data Group)., MI Harris, and RF Hamman, Eds. U.S. Department of Health and Human Sciences, Washington, DC, 1985, pp XII–1 to XII–16. 10 Mazze RS, Sinnock P, Deeb L, and Brimbury JL: An epidemiological model for diabetes mellitus in the United States: Five major complications. Diab Res Clin Pract 1: 185– 191, 1985. 11 Chapman J, Wright AD, Nattrass M, and Fitzgerald MG: Recurrent diabetic ketoacidosis. Diab Med 5: 569– 571, 1988. 12 Fulop M: Recurrent diabetic ketoacidosis. Am J Med 78: 54– 60, 1985. 13 Davis SN, and Stephenson P: Improvement of recurrent diabetic ketoacidosis due to danazol. Practical Diabetes 5: 251, 1988. 14 Schade DS, Eaton RP, Johnston DG, and Alberti KGMM Diabetic Coma: Ketoacidotic and Hyperosmolar. University New Mexico Press, Albuquerque, 1981, pp 57– 71. 15 Knight G, Jennings AM, Boulton AJM, Tomlinson S, and Ward JD: Severe hyperkalaemia and ketoacidosis during routine treatment with an insulin pump. Br Med J 291: 371– 372, 1985. 16 Sheppard MC, and Wright AD: The effect on mortality of low-dose insulin therapy for diabetic ketoacidosis. Diabetes Care 5: 111– 113, 1982. 17 Hockaday TDR, and Alberti KGMM: Diabetic coma. Clin Endocrinol Metab 1: 751– 788, 1972. 18 Balasse EO, and Fery F: Ketone body production and disposal: Effects of fasting, diabetes and exercise. Diab Metab Rev 5: 247– 270, 1989. 19 McGarry JD, Woelrje KF, Kuwajima M, and Foster DW: Regulations of ketogenesis and the renaissance of carnitine palmitoyltransferase. Diab Metab Rev 5: 271– 284, 1989. 20 Keller U, Lustenberger M, Muller-Brand J, Gerber PPG, and Stanffacher W: Human ketone body production and utilization using tracer techniques: Regulation by fatty acids, insulin, catecholamines, and thyroid hormones. Diab Metab Rev 5: 285– 298, 1989. 21 Nosadini R, Avogaro A, Doria A, Fioretto P, Trevisan R, and Morocutti A: Ketone body metabolism: A physiological and clinical overview. Diab Metab Rev 5: 299– 319, 1989. 22 Johnston DG, and Alberti KGMM: Hormonal control of ketone metabolism in the normal and diabetic state. Clin Endocrinol Metab 11: 329– 361, 1982. 23 Swislocki ALM, Chen YDI, Golay A, Chang MO, and Reaven GM: Insulin suppression of free fatty acid concentration in normal individuals and patients with Type 2 (noninsulin dependent) diabetes. Diabetologia 30: 622– 626, 1987. 24 Agius L, Chowdhury MH, Davis SN, and Alberti KGMM: Regulation of ketogenesis, gluconeogenesis and glycogen synthesis by insulin and proinsulin in rat hepatocyte monolayer cultures. Diabetes 35: 1286– 1293, 1986. 25 Keller U, Gerber PP, and Stauffacher W: Fatty acid independent inhibition of hepatic ketone body production by insulin in humans. Am J Physiol 254: E694– E699, 1988. 26 Keller U, Lustenberger M, and Stauffacher W: Effect of insulin on ketone body clearance studied by a ketone body “clamp” technique in normal man. Diabetologia 31: 24– 29, 1988. 27 McGarry JD, Robles-Valdes C, and Foster DW: Role of carnitine in hepatic ketogenesis. Proc. Natl Acad Sci USA 72: 4385– 4388, 1975. 28 Pernet A, Walker M, Gill GV, Orskov H, Alberti KGMM, and Johnston DG: Metabolic effects of adenaline and noradrenaline in man: Studies with somatostatin. Diabete Metab 10: 98– 105, 1984. 29 Alberti KGMM, Christensen NJ, Iverson J, and Orskov H: Role of glucagon and other hormones in development of diabetic ketoacidosis. Lancet 1: 1307– 1311, 1975. 30 Gerich JE, Lorenzi M, Bier DM, Schneider V, Tsalikian E, Karan JH, and Forsham PH: Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon. New Engl J Med 292: 985– 989, 1975. 31 Barnes AJ, Bloom SR, Alberti KGMM, Smythe P, and Alford FP: Ketoacidosis in pancreatectomized man. New Engl J Med 296: 1250– 1254, 1977. 32 Madsbad S, Alberti KGMM, Binder C, Burrin JM, Faber OK, Krarup T, and Regeur L: Role of residual insulin secretion in protecting against ketoacidosis in insulin-dependent diabetes. Br Med J 2: 1257– 1259, 1979. 33 Rechard GA, Jr., Skutches CL, Hoeldtke RD, and Owen OE: Acetone metabolism in humans during diabetic ketoacidosis. Diabetes 35: 668– 674, 1986. 34 Owen OE, Trapp VE, Skutches CL, Mozzoli MA, Hoeldtke RD, Boden G, and Reichard GA, Jr.: Acetone metabolism during diabetic ketoacidosis. Diabetes 31: 224– 248, 1982. 35 Hetenyi G, Jr. and Ferrarotto C: Gluconeogenesis from acetone in starved rats. Biochem J 231: 151– 155, 1985. 36 Miles JM, Rizza Ra, Haymond MW, and Gerich JE: Effect of acute insulin deficiency on glucose and ketone body turnover in man. Evidence for the primary overproduction of glucose and ketone bodies in the genesis of diabetic ketoacidosis. Diabetes 29: 926– 930, 1980. 37 Malchoff CD, Pohl SL, Kaiser DL, and Carey RM: Determinants of glucose and ketoacid concentrations in acutely hyperglycemic diabetic patients. Am J Med 77: 275– 285, 1984. 38 Yki-Jarvinen H, Helve E, and Koivisto VA: Hyperglycemia decreases glucose uptake in type 1 diabetes. Diabetes 36: 892– 896, 1987. 39 Arnfred J, Schmitz O, Hother-Nielsen O, Orskov C, Beck-Nielsen H, Hermansen K, Christensen JS, Alberti KGMM, and Orskov H: Marked impairment of the effect of hyperglycemia on glucose uptake and glucose production in insulin-dependent diabetes. Diabetic Med 5: 755– 760, 1988. 40 Imamura T, Koffler M, Helderman JH, Prince D, Thirlby R, Inman L, and Unger RH: Severe diabetes induced in subtotally depancreatized dogs by sustained hyperglycemia. Diabetes 37: 600– 609, 1988. 41 Hers H-G, and Van Schaflingen E: Fructose 2,6-bisphosphate 2 years after its discovery. Biochem J 206: 1– 12, 1982. 42 Sumi S, Mineo I, Kono N, Shimizu T, Nonaka K, and Tarui S: Decrease in hepatic fructose 2,6-bisphosphate level and fructose 2,6-bisphosphate 2-kinase activity in diabetic mice: A close relationship to the development of ketosis. Biochem Biophys Res Commun 120: 103– 108, 1984. 43 Neely P, El Maghrabi MR, Pilkis SJ, and Claus TH: Effect of diabetes, insulin, starvation and refeeding on the level of rat hepatic fructose 2,6-bisphosphatase. Diabetes 30: 1062– 1067, 1981. 44 Adrogue HJ, Wilson H, Boyd AE, Suki WN, and Eknoyan G: Plasma acid-base patterns in diabetic ketoacidosis. N Engl J Med 307: 1603– 1610, 1982. 45 Brandt KR, and Miles JM: Relationship between severity of hyperglycemia and metabolic acidosis in diabetic ketoacidosis. Mayo Clin Proc 63: 1071– 1074, 1988. 46 Emmett M, and Narins RG: Clinical use of anion gap. Medicine 56: 38– 54, 1977. 47 Capps N, Jessamine J, and Slater S: Diabetic ketoacidosis: A complex mixed acid-base disorder. Scott Med J 31: 182– 183, 1986. 48 Sözen T, Gedik O, and Bayraktar M: Diabetic ketosis with alkalosis in Cushing's syndrome. Isr J Med Sci 23: 907– 909, 1987. 49 Zonszein J, and Baylor P: Diabetic ketoacidosis with alkalosis—A review. West J Med 149: 217– 219, 1988. 50 Ionescu-Tirgoviste C, and Mincu I: The study of potassium metabolism in terms of the gravity of ketoacidosis. Comment with reference to 1000 cases. Rev. Roum Med 14: 13– 22, 1976. 51 Adrogue HJ, Lederer ED, Suki WN, and Eknoyan CG: Determination of plasma potassium levels in diabetic ketoacidosis. Medicine 65: 163– 172, 1986. 52 Pickup JC: Hyperkalemia after interruption of CSII. Diabetologia 29: 823– 824, 1986. 53 Katz Ma: Hyperglycemia-induced hyponatremia—Calculation of expected sodium depression. N Engl J Med 289: 843– 844, 1973. 54 Juan D: Clinical review: The clinical importance of Hypomagnesemia. Surgery 91: 510– 517, 1982. 55 Alberti KGMM, Emerson PM, Darley JH, and Hockaday TDR: 2,3-Diphosphoglycerate and tissue oxygenation in uncontrolled diabetes mellitus. Lancet 2: 391– 2395, 1972. 56 Evan-Wong L, and Davidson RJ: Raised Coulter mean corpuscular volume in diabetic ketoacidosis, and its underlying association with marked hyperosmolarity. J Clin Pathol 36: 334– 336, 1982. 57 Alberti KGMM, and Hockaday TDR: Diabetic coma—A reappraisal. Clin Endocrinol Metab 6: 421– 456, 1977. 58 Paton RC: Haemostatic changes in diabetic coma. Diabetologia 21: 172– 177, 1981. 59 Campbell IW, Duncan LPJ, Innes JA, MacCuish AG, and Munro JF: Abdominal pain in diabetic metabolic decompensation. JAMA 233: 166– 168, 1975. 60 Matz R: Hypothermia in diabetes acidosis. Hormones 3: 36– 41, 1972. 61 Fulop M, Tawnewbaum H, and Dreyer N: Ketotic hyperosmolar coma. Lancet 2: 635– 639, 1973. 62 Warshaw AL, Feller ER, and Lee K-H: On the cause of raised serum amylase in diabetic ketoacidosis. Lancet 1: 929– 931, 1977. 63 Fuller VJ, Colman PG, Harper RW, and Stockigt JR, Transient anterior electrocardiographic changes simulating acute anterior myocardial infarction in diabetic ketoacidosis. Diabetes Care 5: 118– 121, 1984. 64 Soler NG, Bennett MA, Fitzgerald MG, and Malins JM: Electrocardiogram as a guide to potassium replacement in diabetic ketoacidosis. Diabetes 23: 610– 615, 1974. 65 Williams GE: Alcoholic hypoglycaemia and ketoacidosis. Med CN Am 68: 33– 38, 1984. 66 Zadik Z, Blachar Y, Barak Y, and Levin S: Organophosphate poisoning presenting as diabetic ketoacidosis. Toxicology 20: 381– 385, 1983. 67 Moss JM: Diabetic ketoacidosis: Effective low-cost treatment in a community hospital. Southern Med J 80: 875– 881, 1987. 68 Lester F: Ketoacidosis in Ethiopian diabetics. Diabetologia 18: 375– 377, 1980. 69 West ML, Marsden PA, Singer GG, and Halperin ML: Quantitative analysis of glucose loss during acute therapy for hyperglycemic hyperosmolar syndrome. Diabetes Care 9: 465– 471, 1986. 70 Waldhausl W, Kleinberger G, Korn A, Dudczak R, Bratusch-Marrain P, and Nowotny P,: Severe hyperglycaemia: Effects of rehydration on endocrine derangements and blood glucose concentration. Diabetes 28: 577– 584, 1979. 71 Owen OE, Licht JH, and Sapir DG: Renal function and effects of partial rehydration during diabetic ketoacidosis. Diabetes 30: 510– 518, 1981. 72 Hillman K: Fluid resuscitation in diabetic emergencies—A reappraisal. Intensive Care Med 13: 4– 8, 1987. 73 Kitabchi AE: Low-dose insulin therapy in diabetic ketoacidosis: Fact or fiction? Diab Metab Rev 5: 337– 364, 1989. 74 Alberti KGMM, Hockaday TDR, and Turner RC: Small doses of intramuscular insulin in the treatment of diabetic coma. Lancet 2: 515– 522, 1973. 75 McB Page M, Alberti KGMM, Greenwood R, Gumaa KA, Hockaday TDR, Lowy C, Nabarro JDN, Pyke DA, Sonksen PH, Watkins PJ, and West TET: Treatment of diabetic coma with continuous low-dose infusion of insulin. Br Med J 1: 687– 690, 1974. 76 Kitabchi AE, Matteri R, and Murphy MB: Optimal insulin delivery in diabetic ketoacidosis (DKA) and hyperglycaemic, hyperosmolar non ketotic coma (HONC). Diabetes Care 5 (Suppl 1): 78– 87, 1982. 77 Root HF: The use of insulin and abuse of glucose in the treatment of diabetic coma. JAMA 127: 557– 564, 1945. 78 Barrett EJ, De Fronzo RA, Bevilaqua S, and Ferrannini E: Insulin resistance in diabetic ketoacidosis. Diabetes 31: 923– 928, 1982. 79 Luzi L, Barrett EJ, Groop LC, Ferrannini E, and DeFronzo RA: Metabolic effects of low-dose insulin therapy on glucose metabolism in diabetic ketoacidosis. Diabetes 37: 1470– 1477, 1988. 80 Cuthbert C, and Alberti KGMM: Acidemia and insulin resistance in the diabetic ketoacidotic rat. Metabolism 27: 1903– 1916, 1978. 81 Whittaker J, Cuthbert C, Hammond VA, and Alberti KGMM: Effects of metabolic acidosis in vivo on insulin binding to isolated rat adipocytes. Metabolism 31: 553– 557, 1982. 82 Ionescu-Tirgoviste C, Mincu I, and Cheta D: Relationship between the concentration of H+ ions and the efficiency of insulin in the treatment of diabetic ketoacidosis. Endokrinologie 76: 171– 180, 1980. 83 Fisher JN, Shahshahani MN, and Kitabchi AE: Diabetic ketoacidosis: Low-dose insulin therapy by various routes. New Engl J Med 297: 238– 241, 1977. 84 Jos J, Oberkampf B, Couprie C, Paclot C, and Bougneres P: Comparison de deux modes to traitement de l'acidocetose diabetique de l'enfant. Arch Fr Pediatr 45: 15– 19, 1988. 85 Mincou I, Ionescu-Tirgoviste C, Cheta D, and Babes A: Le role de l'apport de glucose dans le traitement de la ceto-acidose diabetique severe. Gazette Med France 86: 1665– 1670, 1979. 86 Soler NG, Bennet MA, Dixon K, Fitzgerald MG, and Malins JM: Potassium balance during treatment of diabetic ketoacidosis with special reference to the use of bicarbonate. Lancet 2: 665– 667, 1972. 87 Schade DS, and Eaton RP: Dose response to insulin in man: Differential effects on glucose and ketone body regulation. J Clin Endocrinol Metab 44: 1038– 1053, 1977. 88 Nichols GL, Kahn T, Sanchez A, and Gabrilove GA: Glucose-induced hyperkalemia in diabetic subjects. Arch Intern Med 141: 49– 53, 1981. 89 Van Gaal LF, De Leeuq IH, and Bekaert JL, Diabetic ketoacidosis—Induced hyperkalemia. Prevalence and possible origin. Intensive Care Med 12: 416– 418, 1986. 90 Malone JL and Brodsky SJ: The value of electrocardiogram monitoring in diabetic ketoacidosis. Diabetes Care 3: 543– 547, 1980. 91 Lever E, and Jaspan JB: Sodium bicarbonate therapy in severe diabetic ketoacidosis. Am J Med 75: 263– 268, 1983. 92 Hale PJ, Crase J, and Natrass M: Metabolic effects of bicarbonate in the treatment of diabetic ketoacidosis. Br Med J 289: 1035– 1038, 1984. 93 Morris LR, Murphy MB, and Kitabchi AE: Bicarbonate therapy in severe diabetic ketoacidosis. Ann Intern Med 105: 836– 840, 1986. 94 Kitabchi AE, and Murphy MB: The use of bicarbonate in diabetic ketoacidosis (DKA). In Diabetes in Medicine. HV Barnes, Ed. Yearbook Publications, Chicago, 1989 (in press). 95 Slovis CM, Mark VGC, Slouis RJ, and Bain RP: Diabetic ketoacidosis and infection: Leukocyte count and differential as early predictors of serious infection. Am J Emerg Med 5: 1– 5, 1987. 96 Tunbridge WMG: Deaths due to diabetic ketoacidosis. Quart J Med 50: 502, 1981. 97 Krane EJ, Rockoff MA, Wallman JK, and Wolfsdorf JI: Subclinical brain swelling in children during treatment of diabetic ketoacidosis. N Engl J Med 312: 1147– 1151, 1985. 98 Hoffman WH, Steinhart CM, ElGammal T, Steele S, Cuadrado AR, and Morse PK: Cranial CT in children and adolescents with diabetic ketoacidosis. Am J Neuroradiol 9: 733– 739, 1988. 99 Rosenbloom AL, Riley WJ, Weber FT, Malone JI, and Donnely WH: Cerebral edema complicating diabetic ketoacidosis in childhood. J Pediatr 96: 357– 361, 1980. 100 Duck SC, and Wyatt DT: Factors associated with brain herniation in the treatment of diabetic ketoacidosis. J Pediatr 113: 10– 14, 1988. 101 Van der Meulen JA, Klip A, and Grinstein S: Possible mechanism for cerebral oedema in diabetic ketoacidosis. Lancet 2: 306– 308, 1987. 102 Shale DJ: The adult respiratory distress syndrome—20 years on. Thorax 42: 641– 645, 1987. 103 Fowler AA, Hamman RF, Good JT, Benson KN, Baird M, Eberle DJ, Petty TL, and Hyers TM: Adult respiratory distress syndrome: Risk with common predispositions. Ann Intern Med 98: 593– 597, 1983. 104 Carroll P, and Matz R: Adult respiratory distress syndrome complicating severely uncontrolled diabetes mellitus: Report of nine cases and a review of the literature. Diabetes Care 5: 574– 580, 1982. 105 Brun-Buisson CJL, Bonnet F, Bergeret S, Lemaire F, and Rapin M: Recurrent high-permeability pulmonary edema associated with diabetic ketoacidosis. Crit Care Med 13: 55– 56, 1985. 106 Leonard RCF, Asplin C, McCormick CV, and Hockaday TDR: Acute respiratory distress syndrome in diabetic ketoacidosis: Possible contribution of low colloid osmotic pressure. Br Med J 286: 760– 762, 1983. 107 Keller U, Berger W, Ritz R, and Truog P: Course and prognosis of 86 episodes of diabetic coma. A five year experience with a uniform schedule of treatment. Diabetologia 11: 93– 100, 1975. 108 Clements RS, Jr., and Vourganti B: Fatal diabetic ketoacidosis: Major causes and approaches to their prevention. Diabetes Care 1: 314– 325, 1978 Citing Literature Volume5, Issue8December 1989Pages 651-663 ReferencesRelatedInformation
Referência(s)